For tapentadol, only two in the three randomized controlled trials conducted to date in diabetic peripheral neuropathy have concluded that tapentadol is outstanding to placebo [sixty four, seventy two]. On the basis of your obtainable facts, its efficacy With this indication was viewed as inferior to that of tramadol, and possibly overestimated by